Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis

NCT05603702 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05603702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05603702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Lead sponsor
Indiana University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 17, 2023
Completion date
March 31, 2027
Enrollment
21 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic abdominal pain, chronic pain, chronic pain syndrome, chronic pancreatitis, ercp, hyperalgesia, opioid dependence, opioid use disorder, opioid-related disorders, pancreatic surgery